東華大學圖書館 |

語系: 繁體中文

說明(常見問題)

回圖書館首頁

手機版館藏查詢

登入

回首頁

切換: 標籤 | MARC模式 | ISBD

Role of Adaptor Protein AP-3 in Biog...

Sirkis, Daniel Wesley.

FindBook

Google Book

Amazon

博客來

Role of Adaptor Protein AP-3 in Biogenesis of the Regulated Secretory Pathway.

紀錄類型:	書目-電子資源 : Monograph/item
正題名/作者:	Role of Adaptor Protein AP-3 in Biogenesis of the Regulated Secretory Pathway./
作者:	Sirkis, Daniel Wesley.
出版者:	Ann Arbor : ProQuest Dissertations & Theses, : 2012,
面頁冊數:	190 p.
附註:	Source: Dissertation Abstracts International, Volume: 74-06(E), Section: B.
Contained By:	Dissertation Abstracts International74-06B(E).
標題:	Cellular biology. -
電子資源:	http://pqdd.sinica.edu.tw/twdaoapp/servlet/advanced?query=3553871
ISBN:	9781267935373

Role of Adaptor Protein AP-3 in Biogenesis of the Regulated Secretory Pathway.
Sirkis, Daniel Wesley.

Role of Adaptor Protein AP-3 in Biogenesis of the Regulated Secretory Pathway. - Ann Arbor : ProQuest Dissertations & Theses, 2012 - 190 p.

Source: Dissertation Abstracts International, Volume: 74-06(E), Section: B.

Thesis (Ph.D.)--University of California, San Francisco, 2012.

This item is not available from ProQuest Dissertations & Theses.

The regulated secretion of peptide hormones, neuropeptides and many growth factors depends on their sorting into large dense-core vesicles (LDCVs) capable of regulated exocytosis. LDCVs form at the trans-Golgi network, but the mechanisms that sort proteins to this regulated secretory pathway and the cytosolic machinery that produces LDCVs remain poorly understood. Recently, we used RNAi to identify a role for heterotetrameric adaptor protein AP-3 in regulated secretion and LDCV formation. Indeed, mocha mice lacking AP-3 have a severe neurological and behavioral phenotype, but this has been attributed to a role for AP-3 in the endolysosomal pathway, and the contribution of dysregulated peptide hormone secretion has not been investigated. We now find that adrenal chromaffin cells from mocha animals show increased constitutive exocytosis of both soluble and membrane LDCV cargo, reducing the extent of stimulation. We also observe increased basal release of insulin and glucagon from AP-3-deficient pancreatic islet cells, suggesting a widespread disturbance in the release of peptide hormones. AP-3 exists as both ubiquitous and neuronal isoforms, but we find that loss of both is required to impair LDCV production. In addition, we show that loss of the related adaptor protein AP-1 has no effect on regulated secretion but greatly exacerbates the effect of AP-3 RNAi, indicating distinct roles for the two adaptors in formation of the regulated secretory pathway. Finally, quantitative proteomic analysis of LDCVs reveals a number of functionally important membrane proteins whose levels are significantly altered by the loss of AP-3. In particular, ectopic localization of the t-SNARE, syntaxin-1A, to LDCVs may account for the impairment in regulated secretion observed after loss of AP-3. Taken together, these results support the notion that AP-3-directed sorting maintains the normal complement of LDCV membrane proteins, thus ensuring the proper regulation of secretion.

ISBN: 9781267935373Subjects--Topical Terms:

3172791
Cellular biology.

Role of Adaptor Protein AP-3 in Biogenesis of the Regulated Secretory Pathway.
LDR:03033nmm a2200313 4500 001 2163423
005 20181022132250.5
008 190424s2012 ||||||||||||||||| ||eng d
020 $a 9781267935373
035 $a (MiAaPQ)AAI3553871
035 $a (MiAaPQ)ucsf:10671
035 $a AAI3553871
040 $a MiAaPQ $c MiAaPQ
100 1 $a Sirkis, Daniel Wesley. $3 3351442
245 1 0 $a Role of Adaptor Protein AP-3 in Biogenesis of the Regulated Secretory Pathway.
260 1 $a Ann Arbor : $b ProQuest Dissertations & Theses, $c 2012
300 $a 190 p.
500 $a Source: Dissertation Abstracts International, Volume: 74-06(E), Section: B.
500 $a Adviser: Robert H. Edwards.
502 $a Thesis (Ph.D.)--University of California, San Francisco, 2012.
506 $a This item is not available from ProQuest Dissertations & Theses.
520 $a The regulated secretion of peptide hormones, neuropeptides and many growth factors depends on their sorting into large dense-core vesicles (LDCVs) capable of regulated exocytosis. LDCVs form at the trans-Golgi network, but the mechanisms that sort proteins to this regulated secretory pathway and the cytosolic machinery that produces LDCVs remain poorly understood. Recently, we used RNAi to identify a role for heterotetrameric adaptor protein AP-3 in regulated secretion and LDCV formation. Indeed, mocha mice lacking AP-3 have a severe neurological and behavioral phenotype, but this has been attributed to a role for AP-3 in the endolysosomal pathway, and the contribution of dysregulated peptide hormone secretion has not been investigated. We now find that adrenal chromaffin cells from mocha animals show increased constitutive exocytosis of both soluble and membrane LDCV cargo, reducing the extent of stimulation. We also observe increased basal release of insulin and glucagon from AP-3-deficient pancreatic islet cells, suggesting a widespread disturbance in the release of peptide hormones. AP-3 exists as both ubiquitous and neuronal isoforms, but we find that loss of both is required to impair LDCV production. In addition, we show that loss of the related adaptor protein AP-1 has no effect on regulated secretion but greatly exacerbates the effect of AP-3 RNAi, indicating distinct roles for the two adaptors in formation of the regulated secretory pathway. Finally, quantitative proteomic analysis of LDCVs reveals a number of functionally important membrane proteins whose levels are significantly altered by the loss of AP-3. In particular, ectopic localization of the t-SNARE, syntaxin-1A, to LDCVs may account for the impairment in regulated secretion observed after loss of AP-3. Taken together, these results support the notion that AP-3-directed sorting maintains the normal complement of LDCV membrane proteins, thus ensuring the proper regulation of secretion.
590 $a School code: 0034.
650 4 $a Cellular biology. $3 3172791
650 4 $a Neurosciences. $3 588700
690 $a 0379
690 $a 0317
710 2 $a University of California, San Francisco. $b Pharmaceutical Sciences and Pharmacogenomics. $3 1023490
773 0 $t Dissertation Abstracts International $g 74-06B(E).
790 $a 0034
791 $a Ph.D.
792 $a 2012
793 $a English
856 4 0 $u http://pqdd.sinica.edu.tw/twdaoapp/servlet/advanced?query=3553871